原发性皮肤黑色素瘤大分割辅助放疗后手术重建毒性
本研究回顾2008-2021年193例原发性皮肤黑色素瘤患者,均行肿瘤切除与重建(移植、皮瓣或皮肤替代物)后接受5×6 Gy辅助放疗。仅5%需手术修正,其中一半发生在放疗后,均为头皮移植重建,提示充分愈合时间下辅助放疗仅轻度增加重建并发症风险。
要点
- 皮肤黑色素瘤重建后大分割辅助放疗5×6 Gy,手术修正风险低(5%)。
- 放疗后需手术修正者均为头皮移植重建,时间跨度大。
- 移植失败半数在放疗前、半数在放疗后,提示放疗影响有限。
核心结论
- 对涉及移植、皮瓣或皮肤替代物的手术重建,辅助大分割放疗后手术修正风险低。
- 移植失败半数发生在辅助放疗前、半数在放疗后,提示给予充分愈合时间时辅助放疗仅轻度增加重建后并发症风险。
研究设计与样本
- 单中心回顾性研究,纳入2008-2021年接受原发性肿瘤切除与重建后行5×6 Gy辅助放疗的皮肤黑色素瘤患者193例。
- 评估治疗后并发症详情,包括手术修正情况。
主要发现
- 193例患者中,70%有心血管疾病、64%超重、23%有糖尿病,至少1项伤口愈合风险因素。
- 89%肿瘤位于头颈部,重建从手术到放疗的中位时间为7周(IQR 5-9周)。
- 重建方式中皮肤移植占62%、皮瓣占44%,86%(166例)采用电子线放疗。
- 放疗后需手术修正者从重建到放疗时间5-11周,从放疗到手术修正时间2-28个月。
临床怎么用
- 对皮肤黑色素瘤术后重建患者,给予充分愈合时间后行大分割辅助放疗(5×6 Gy)重建并发症风险低,可考虑应用。
- 头皮移植重建患者放疗后仍需关注晚期手术修正可能,虽风险不高但时间跨度大。
局限性
- 单中心回顾性研究,样本量有限(193例),需更大样本验证。
- 未设对照组,无法直接比较未放疗者的手术修正风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adjuvant radiation therapy (RT) to a cutaneous target has been associated with elevated risk of surgical complications such as graft, flap, or skin substitute reconstruction failure. We sought to better quantify the risk of surgical site complications after hypofractionated adjuvant RT delivered in the modern era to patients undergoing surgical reconstruction for their primary site cutaneous melanoma. METHODS AND MATERIALS: We reviewed clinical data on all patients treated for cutaneous melanoma at our center between 2008 and 2021 with primary tumor resection and reconstruction (graft, flap, or skin substitute), followed by 5 × 6 Gy RT. Details on post-treatment complications were assessed. RESULTS: A total of 193 patients with melanoma undergoing surgical reconstruction followed by hypofractionated RT were identified. Most patients carried at least 1 risk factor for wound healing complications (70% with cardiovascular disease, 64% overweight, and 23% with diabetes). Most tumors were located in the head and neck (89%). Patients initiated RT a median of 7 weeks (IQR, 5-9 weeks) from surgical reconstruction. Skin grafts were used in 62% of reconstructions, and flaps used in 44%. Electron-based RT was used for the majority of patients (n = 166, 86%). Ten patients (5%) required surgical revision after reconstruction, with half occurring after RT. The primary reconstruction for all 5 patients requiring surgical revision after RT was graft reconstruction of the scalp, with a wide range of times from reconstruction to RT (5-11 weeks) and a wide range of times from RT to surgical revision (2-28 months). CONCLUSIONS: The risk of surgical revision after adjuvant hypofractionated RT to a surgical reconstruction involving a graft, flap, or skin substitute is low. Half of graft failures occurred before adjuvant RT and half after, which suggests that adjuvant RT only marginally increases the risk of postreconstruction complications if adequate time for healing is given.
引用
- Yang NX, Rosamilia GL, Arifin AJ, et al. Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Pract Radiat Oncol. 2025. PMID: 41380909. doi:10.1016/j.prro.2025.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。